“Marrow Asleep or Awake?”: William Aird Simplifies Anemia Diagnosis
William Aird, Professor of Medicine at Harvard Medical School, posted on X:
՛՛1/4
RETIC COUNT
When evaluating anemia, I teach my trainees to start with a simple binary:
Is the bone marrow responding appropriately or not?
That answer lies in a single number: the absolute reticulocyte count (ARC).
2/4
- ARC < 0.12 ×10⁶/µL → hypoproliferative (marrow asleep).
- ARC ≥ 0.12 ×10⁶/µL → hyperproliferative (marrow awake).
It’s a light switch, not a dimmer.
Once the marrow’s “on,” the next question isn’t how high, but why.
3/4
Getting granular (0.15 vs 0.20) adds math, not meaning.
At that point, you’ve already learned the key thing:
the marrow can respond, so look for blood loss or hemolysis, not marrow failure.
4/4
Clinical reasoning often starts binary and gets nuanced later (i.e., decision thresholds are categorical).
The ARC is one of those places where simple still works.
Below 0.12 → asleep.
Above 0.12 → awake.
Everything else is physiology, not management.՛՛
Stay updated with Hemostasis Today.
-
Mar 19, 2026, 18:29Rameez Ashraff: Have You Noticed Neutrophil Inclusions in a Thrombocytopenia Smear?
-
Mar 19, 2026, 18:07Leonardo Roever: A Consensus Framework for Biomarker Research and Clinical Translation in Stroke
-
Mar 19, 2026, 17:49Matteo Foschi: Breaktrough Stroke on Oral Anticoaugulants for Atrial Fibrillation
-
Mar 19, 2026, 17:30UK Haemophilia Society Continues to Empower Individuals and Families Through Advocacy, Education, and Community Support – WFH
-
Mar 19, 2026, 17:20Dimitrios Nikas: Stroke During TAVI Procedures Still Remains Noticeable High
-
Mar 19, 2026, 17:14Akinchan Bhardwaj: Differences in Bleeding Outcomes Among DOACs
-
Mar 19, 2026, 17:03How Personal Experiences Can Support Self‑Advocacy and Help Improve Healthcare Outcomes – Hemophilia Alliance
-
Mar 19, 2026, 16:54X. Long Zheng: Unpacking the Real-World Challenges of ADAMTS13 on ISTH Pulse Podcast
-
Mar 19, 2026, 16:50Zain Khalpey: Predictive Imaging and AI in Aortic Dissection Risk Assessment